普通变异型免疫缺陷病患者风湿病表现的表型特征分析
该研究基于美国免疫缺陷网络(USIDNET)登记库中870例儿童及成人普通变异型免疫缺陷病(CVID)患者进行回顾性分析,发现医生报告的风湿病患病率为5.9%(n=51),以炎症性关节炎、干燥综合征、SLE、雷诺综合征和血管炎为主;风湿病组女性比例更高(女男比3.3:1)且非白人比例增加(p<0.05),但两组在CD19+ B细胞计数、CD4/CD8比值、IgA和IgM上无显著差异。
要点
- CVID患者中医生报告的风湿病患病率为5.9%(51/870)。
- 风湿病组女性与男性比为3.3:1,非白人比例较非炎症性CVID组增加(p<0.05)。
- 两组间CD19+ B细胞计数、CD4/CD8比值、IgA和IgM均无显著差异。
核心结论
- 研究强调了原发性抗体免疫缺陷与系统性风湿病可共存,描述了CVID患者风湿病表现谱,并在美国最大CVID登记库中对比了相关人口学、临床和免疫表型参数的差异。
- 作者认为,进一步阐明系统性自身免疫与体液免疫缺陷之间的联系可为理解这些相关疾病的免疫异常提供新见解。
研究设计与样本
- 对美国免疫缺陷网络(USIDNET)登记库中870例儿童及成人CVID患者进行回顾性分析,比较伴风湿病者与非炎症性CVID者在临床特征、感染史和基础免疫表型上的差异。
主要发现
- 医生报告的风湿病见于5.9%的CVID患者(n=51)。
- 风湿病组女性与男性比为3.3:1,非白人患者比例增加(p<0.05)。
- 具体风湿病包括炎症性关节炎(n=18)、干燥综合征(n=11)、SLE(n=8)、雷诺综合征(n=8)、血管炎(n=9)、MCTD(n=3)及其他(n=5)。
- 约三分之一患者的风湿病与另一种炎症性并发症或恶性肿瘤相关。
- 在CD19+ B细胞计数、CD4/CD8比值、IgA和IgM比较中,两组间无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文称尽管存在局限性,但未在摘要中具体列出局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Patients with common variable immunodeficiency (CVID) have a higher incidence of rheumatologic disorders. To delineate this clinical association, we investigated the phenotypic features of patients with CVID affected by these conditions. METHODS: We conducted a retrospective analysis of 870 pediatric and adult patients with CVID included in the United States Immunodeficiency Network (USIDNET) registry. Outcomes included clinical characteristics (age, gender, ethnicity, rheumatologic diagnosis, and comorbidities), infectious history and basic immunophenotype (serum immunoglobulin levels, CD19+ B cells, and CD4/CD8 ratio) in patients with CVID and rheumatologic disorders compared to those with non-inflammatory CVID. Demographic and clinical data were compared using chi-square, Fisher's exact or Wilcoxon-Mann-Whitney tests. Non-parametric tests, single and multiple logistic regression models were used to evaluate the relationship between CVID-associated rheumatologic disorders and basic immunophenotypic parameters (IgA, IgM, CD19+ B-cell counts, and CD4/CD8 ratios). RESULTS: Physician-reported rheumatic diseases were present in 5.9% of patients with CVID (n = 51) included in the registry. Although CVID affects both sexes equally, and patients are of predominantly White-Caucasian ethnicity, there were more females (3.3:1 female to male ratio) and increased proportion of non-white patients in the rheumatologic disease group (p < 0.05). Specific disorders included: inflammatory arthritis (n = 18), Sjogren's syndrome (n = 11), SLE (n = 8), Raynaud's syndrome (n = 8), vasculitis (n = 9), MCTD (n = 3), and other (n = 5). In about one-third of patients, a rheumatologic condition was associated with an additional inflammatory complication or malignancy. In regards to the immunophenotype parameters compared (CD19+ B-cell counts, CD4/CD8 ratio, IgA, and IgM), no significant differences were demonstrated between the two groups. CONCLUSION: Our findings highlight the coexistence of primary antibody immunodeficiencies and systemic rheumatologic disorders, describe the spectrum of rheumatologic manifestations, and contrast differences in relevant demographic, clinical and immunophenotype parameters in the largest registry of CVID patients in the U.S. In spite of its limitations, our study details the intersection of systemic autoimmunity and CVID and provides valuable insights into these two groups of disorders. Further delineating the link between systemic autoimmunity and humoral immunodeficiencies can provide novel insights into the immune abnormalities underlying these related conditions.
引用
- Gutierrez MJ, Sullivan KE, Fuleihan R, et al. Phenotypic characterization of patients with rheumatologic manifestations of common variable immunodeficiency. Semin Arthritis Rheum. 2018. PMID: 29599028. doi:10.1016/j.semarthrit.2018.02.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。